Genome sequencing in congenital cataracts improves diagnostic yield
- PMID: 34101287
- DOI: 10.1002/humu.24240
Genome sequencing in congenital cataracts improves diagnostic yield
Abstract
Congenital cataracts are one of the major causes of childhood-onset blindness around the world. Genetic diagnosis provides benefits through avoidance of unnecessary tests, surveillance of extraocular features, and genetic family information. In this study, we demonstrate the value of genome sequencing in improving diagnostic yield in congenital cataract patients and families. We applied genome sequencing to investigate 20 probands with congenital cataracts. We examined the added value of genome sequencing across a total cohort of 52 probands, including 14 unable to be diagnosed using previous microarray and exome or panel-based approaches. Although exome or genome sequencing would have detected the variants in 35/52 (67%) of the cases, specific advantages of genome sequencing led to additional diagnoses in 10% (5/52) of the overall cohort, and we achieved an overall diagnostic rate of 77% (40/52). Specific benefits of genome sequencing were due to detection of small copy number variants (2), indels in repetitive regions (2) or single-nucleotide variants (SNVs) in GC-rich regions (1), not detectable on the previous microarray, exome sequencing, or panel-based approaches. In other cases, SNVs were identified in cataract disease genes, including those newly identified since our previous study. This study highlights the additional yield of genome sequencing in congenital cataracts.
Keywords: cataracts; genome sequencing; genomics; microphthalmia.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Abecasis, G. R., Auton, A., Brooks, L. D., DePristo, M. A., Durbin, R. M., Handsaker, R. E., Kang, H. M., Marth, G. T., & McVean, G. A. (2012). An integrated map of genetic variation from 1,092 human genomes. Nature, 491(7422), 56-65.
-
- Aldahmesh, M. A., Khan, A. O., Mohamed, J., & Alkuraya, F. S. (2011). Novel recessive BFSP2 and PITX3 mutations: Insights into mutational mechanisms from consanguineous populations. Genetics in Medicine, 13(11), 978-981. https://doi.org/10.1097/GIM.0b013e31822623d5
-
- Anand, D., Agrawal, S. A., Slavotinek, A., & Lachke, S. A. (2018). Mutation update of transcription factor genes FOXE3, HSF4, MAF, and PITX3 causing cataracts and other developmental ocular defects. Human Mutation, 39(4), 471-494. https://doi.org/10.1002/humu.23395
-
- Bagnall, R. D., Ingles, J., Dinger, M. E., Cowley, M. J., Ross, S. B., Minoche, A. E., Lal, S., Turner, C., Colley, A., Rajagopalan, S., Berman, Y., Ronan, A., Fatkin, D., & Semsarian, C. (2018). Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 72(4), 419-429. https://doi.org/10.1016/j.jacc.2018.04.078
-
- Deml, B., Reis, L. M., Maheshwari, M., Griffis, C., Bick, D., & Semina, E. V. (2014). Whole exome analysis identifies dominant COL4A1 mutations in patients with complex ocular phenotypes involving microphthalmia. Clinical Genetics, 86(5), 475-481. https://doi.org/10.1111/cge.12379
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous